Pages that link to "Q36447664"
Jump to navigation
Jump to search
The following pages link to Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy (Q36447664):
Displaying 47 items.
- Microbial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer Treatment (Q28074931) (← links)
- Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy (Q37690917) (← links)
- UXT-AS1-induced alternative splicing of UXT is associated with tumor progression in colorectal cancer (Q37743497) (← links)
- Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems (Q38735423) (← links)
- The isoflavone fraction from soybean presents mRNA maturation inhibition activity. (Q38737423) (← links)
- Unmasking the U2AF homology motif family: a bona fide protein-protein interaction motif in disguise (Q39010502) (← links)
- Splicing factor gene mutations in hematologic malignancies (Q39035441) (← links)
- The emerging role of alternative splicing in senescence and aging. (Q39432413) (← links)
- Screening for small molecule inhibitors of HIV-1 Gag expression (Q40165444) (← links)
- The role of alternative splicing in cancer (Q42282317) (← links)
- PRPF8 is important for BRCA1-mediated homologous recombination (Q47096369) (← links)
- Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools. (Q47110708) (← links)
- Small-molecule flunarizine increases SMN protein in nuclear Cajal bodies and motor function in a mouse model of spinal muscular atrophy (Q49389328) (← links)
- C3G dynamically associates with nuclear speckles and regulates mRNA splicing. (Q51736755) (← links)
- Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics. (Q52564290) (← links)
- Vesiculated Long Non-Coding RNAs: Offshore Packages Deciphering Trans-Regulation between Cells, Cancer Progression and Resistance to Therapies. (Q53489250) (← links)
- Alternative mRNA Splicing in the Pathogenesis of Obesity. (Q54971907) (← links)
- Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability. (Q54978916) (← links)
- Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype. (Q54981975) (← links)
- Targeting Splicing in Prostate Cancer. (Q55128284) (← links)
- Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity. (Q55137359) (← links)
- Imaging of pre-mRNA splicing in living subjects using a genetically encoded luciferase reporter. (Q55291401) (← links)
- Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells. (Q55449946) (← links)
- Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies (Q57029282) (← links)
- The Krebs Cycle Connection: Reciprocal Influence Between Alternative Splicing Programs and Cell Metabolism (Q57491556) (← links)
- Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma (Q58603892) (← links)
- NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancer (Q58799614) (← links)
- Aberrant RNA Splicing in Cancer and Drug Resistance (Q59791008) (← links)
- Epigenetic regulation of alternative splicing (Q60921915) (← links)
- Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability (Q64106877) (← links)
- Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients (Q64248702) (← links)
- Tumor-associated intronic editing of HNRPLL generates a novel splicing variant linked to cell proliferation (Q88698322) (← links)
- Splice Modulation Synergizes Cell Cycle Inhibition (Q89467704) (← links)
- Systemic Analysis of RNA Alternative Splicing Signals Related to the Prognosis for Head and Neck Squamous Cell Carcinoma (Q89967045) (← links)
- Clinical and functional significance of CHK1-S, an alternatively spliced isoform of the CHK1 gene, in hepatocellular carcinoma (Q90481284) (← links)
- Systemic Analysis of the Prognosis-Related RNA Alternative Splicing Signals in Melanoma (Q90558198) (← links)
- Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data (Q90690525) (← links)
- Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events (Q90705843) (← links)
- Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma (Q90727627) (← links)
- Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data (Q91574624) (← links)
- Food-Derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites (Q91759799) (← links)
- Destabilization of the human RED-SMU1 splicing complex as a basis for host-directed antiinfluenza strategy (Q91930483) (← links)
- Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology (Q92081372) (← links)
- Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma (Q92368100) (← links)
- Identification of prognosis-related alternative splicing events in kidney renal clear cell carcinoma (Q93140000) (← links)
- Function, clinical application, and strategies of Pre-mRNA splicing in cancer (Q93337951) (← links)
- A Comprehensive Overview of Structure-Activity Relationships of Small-Molecule Splicing Modulators Targeting SF3B1 as Anticancer Agents (Q100513059) (← links)